Morgan Stanley Tekla Life Sciences Investors Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Morgan Stanley holds 870,658 shares of HQL stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
870,658
Previous 766,209
13.63%
Holding current value
$14.5 Million
Previous $9.82 Million
37.58%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding HQL
# of Institutions
92Shares Held
9.37MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY2.59MShares$43.1 Million1.2% of portfolio
-
Penserra Capital Management LLC Orinda, CA794KShares$13.2 Million0.16% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL423KShares$7.04 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY403KShares$6.72 Million0.5% of portfolio
-
Lpl Financial LLC Fort Mill, SC374KShares$6.23 Million0.0% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...